Navigation Links
Examining the Lacey Act
Date:9/11/2007

Andrea Fowler, David Lodge, and Jennifer Hsia (University of Notre Dame) examined the efficacy of the Lacey Act in their research communication, Failure of the Lacey Act to protect US ecosystems against animal invasions. The study appears in the September issue of Frontiers in Ecology and the Environment.

With over 100 years on the books (passed in 1900), the Lacey Act is the main legal defense against invasive animal species. The injurious wildlife provision of the Lacey Act seeks to regulate foreign invasive species that may damage ecosystems, replace native populations, and kill off valuable natural resources and fisheries.

If the US is to reduce the probability of future damage from invasive animal species, revision or replacement of the Lacey Acts injurious wildlife provision is essential, say the authors. The contemporary threat of invasive species has far outstripped current authority and practice under this statute.

Examining all Federal Register documents, Fowler and colleagues searched the listed names of organisms, references to the Lacey Act, and references to injurious wildlife to determine which species were listed, considered for listing, and either added or not added to the list.

Many animals were already established when they were added to the list and continued to spread after their listing. The most common way to begin the process of listing a species in the last 25 years has been by petitioning the U.S. Fish and Wildlife Service. However, by March 1, 2007, when the authors wrote the paper, it took an average of more that three and a half years to list a species in this way.

According to the report, the lack of an efficient and consistently applied risk assessment procedure undermine the Lacey Act. Currently, most imported species only need to be declared to customs or permitted through the US Fish and Wildlife Service. The act was expanded from mammals and birds to include mollusks, crustaceans, reptiles, and amphibians in the late 1960s and early 1980s. In the 1970s there was a movement to limit importation to a list of low-risk wildlife, but the list was never implemented.

Fowler et. al. point out that the Lacey Act contains no authority or funding to manage the spread of established wild invasive species, which will do little to slow down organisms already present in the US.

The researchers suggest that prescreening, as well as switching from the use of a list of banned animals to approved species, would better protect the nations environment and natural resources.


'/>"/>

Contact: Annie Drinkard
annie@esa.org
Ecological Society of America
Source:Eurekalert

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/18/2017)... , Jan. 18, 2017  In vitro diagnostic (IVD) ... mergers and acquisitions (M&A), and Kalorama Information expects that ... acquisitions have been shifting. Generally, uncertainty in reimbursement and ... the U.S. has changed the acquisitions landscape. Instead of ... in companies buying partners outside of their home country ...
(Date:1/12/2017)... NEW YORK , Jan. 12, 2017  New research ... around the office of the future.  1,000 participants were simply ... last three months which we may consider standard issue.  Insights ... office of 2017 were also gathered from futurists and industry ... and Dr. James Canton .  Some ...
(Date:1/6/2017)... , Jan. 6, 2017  Privately-held CalciMedica, Inc., ... in healthy volunteers of a novel calcium release-activated ... acute pancreatitis. Acute pancreatitis, sudden ... mild disorder, but can be very serious.  In severe ... sepsis, where extended hospital stays, time in the ...
Breaking Biology News(10 mins):
(Date:1/19/2017)... ... 18, 2017 , ... LabRoots , the leading provider ... world, was today awarded the "Best Science & Technology Social Networking Service 2016" ... decided upon by a dedicated team of researchers and analysts. , The 2016 ...
(Date:1/19/2017)... , Jan. 18, 2017  Northwest Biotherapeutics, Inc. ... DCVax® personalized immune therapies for operable and inoperable solid ... , Chief Technical Officer of NW Bio, will present ... 19, 2017, at the Hyatt Regency Hotel in ... will chair the session entitled "New Therapeutic Approaches – ...
(Date:1/18/2017)... 2017 According to a new market research report "In ... Disease), & End User (Molecular Diagnostic Laboratories, Academic and Research Institutions) - Global ... 739.9 Million by 2021 from USD 557.1 Million in 2016, growing at a ... ... MarketsandMarkets Logo ...
(Date:1/18/2017)... , ... January 18, 2017 , ... ... Clinical Ops Executives 2017 in its continued commitment to the advancement of the ... to discuss current issues related to clinical trial planning and management. , ...
Breaking Biology Technology: